Evidence map›Paper›PMID 34635185›Full record

ArticleNeurological research and practice2021

Paraneoplastic encephalomyeloradiculits with multiple autoantibodies against ITPR-1, GFAP and MOG: case report and literature review.

Anna Cirkel, Klaus-Peter Wandinger, Claudia Ditz, Jan Leppert, Lars Hanker, Christoph Cirkel, Alexander Neumann, Jan Brocke, Romana Höftberger, Lars Komorowski and 5 more

Open access · diamondAbstract read
In one paragraph

Article in Neurological research and practice, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.4field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Assessment of concurrent neoplasms and a paraneoplastic association in MOGAD.Annals of clinical and translational neurology · 2025
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

Anna CirkelDepartment of Neurology, University Hospital of Schleswig-Holstein Lübeck, Lübeck, Germany. anna.cirkel@neuro.uni-luebeck.de.ORCID http://orcid.org/0000-0001-8637-9637
Klaus-Peter WandingerDepartment of Neurology, University Hospital of Schleswig-Holstein Lübeck, Lübeck, Germany.
Claudia DitzDepartment of Neurosurgery, University Hospital of Schleswig-Holstein Lübeck, Lübeck, Germany.
Jan LeppertDepartment of Neurosurgery, University Hospital of Schleswig-Holstein Lübeck, Lübeck, Germany.
Lars HankerDepartment of Gynecology, University Hospital of Schleswig-Holstein Lübeck, Lübeck, Germany.
Christoph CirkelDepartment of Gynecology, University Hospital of Schleswig-Holstein Lübeck, Lübeck, Germany.
Alexander NeumannDepartment of Neuroradiology, University Hospital of Schleswig-Holstein Lübeck, Lübeck, Germany.
Jan BrockeNeurological Rehabilitation Center, Segeberger Kliniken, Bad Segeberg, Germany.
Romana HöftbergerInstitute of Neurology, Medical University Vienna, Vienna, Austria.
Lars KomorowskiInstitute of Experimental Immunology, Euroimmun AG, Lübeck, Germany.
Sven PernerDepartment of Pathology, University Hospital of Schleswig-Holstein Lübeck, Lübeck, Germany.
Frank LeypoldtDepartment of Neurosurgery, University Hospital of Schleswig-Holstein Lübeck, Lübeck, Germany.
Tobias Wagner-AltendorfDepartment of Neurology, University Hospital of Schleswig-Holstein Lübeck, Lübeck, Germany.
Thomas F MünteDepartment of Neurology, University Hospital of Schleswig-Holstein Lübeck, Lübeck, Germany.
Georg RoylDepartment of Neurology, University Hospital of Schleswig-Holstein Lübeck, Lübeck, Germany.
University Hospital Schleswig-Holstein · DEEuroimmun Medizinische Labordiagnostika (Germany) · DESegeberger Kliniken · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRecently, antibodies against the alpha isoform of the glial-fibrillary-acidic-protein (GFAPα) were identified in a small series of patients with encephalomyelitis. Coexisting autoantibodies (NMDA receptor, GAD65 antibodies) have been described in a few of these patients. We describe a patient with rapidly progressive encephalomyeloradiculitis and a combination of anti-ITPR1, anti-GFAP and anti-MOG antibodies. CASE PRESENTATION AND LITERATURE REVIEW: A 44-year old caucasian woman with a flu-like prodrome presented with meningism, progressive cerebellar signs and autonomic symptoms, areflexia, quadriplegia and respiratory insufficiency. MRI showed diffuse bilateral T2w-hyperintense brain lesions in the cortex, white matter, the corpus callosum as well as a longitudinal lesion of the medulla oblongata and the entire spinal cord. Anti-ITPR1, anti-GFAP and anti-MOG antibodies were detected in cerebrospinal fluid along with lymphocytic pleocytosis. Borderline tumor of the ovary was diagnosed. Thus, the disease of the patient was deemed to be paraneoplastic. The patient was treated by surgical removal of tumor, steroids, immunoglobulins, plasma exchange and rituximab. Four months after presentation, the patient was still tetraplegic, reacted with mimic expressions to pain or touch and could phonate solitary vowels. An extensive literature research was performed.

conclusionOur case and the literature review illustrate that multiple glial and neuronal autoantibodies can co-occur, that points to a paraneoplastic etiology, above all ovarian teratoma or thymoma. Clinical manifestation can be a mixture of typically associated syndromes, e.g. ataxia associated with anti-ITPR1 antibodies, encephalomyelitis with anti-GFAPα antibodies and longitudinal extensive myelitis with anti-MOG antibodies.

Indexed as

AutoantibodyEncephalitisEncephalomyelitisEncephalomyeloradiculitsGFAPITPR-1MOGMultiple antibodiesParaneoplastic

Identifiers

PMID34635185
PMCPMC8504129
OpenAlexW3205988501

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.